Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis.

@article{Hawton2013SquintingTL,
  title={Squinting through layers of fog: assessing the cost effectiveness of treatments for multiple sclerosis.},
  author={Annie Hawton and James Shearer and Elizabeth Goodwin and Colin Green},
  journal={Applied health economics and health policy},
  year={2013},
  volume={11 4},
  pages={331-41}
}
BACKGROUND Multiple sclerosis (MS) is a chronic neurological disorder, which can lead to a wide range of disabling symptoms. The condition has a significant negative impact on health-related quality of life, and the economic cost of the disease is substantial. Decision-making regarding treatments for MS, and particularly disease-modifying interventions, has… CONTINUE READING